XML 56 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Cash Proceeds and Aggregate Fair Value of Stock Options Exercised Cash proceeds from, and the intrinsic value of, stock options exercised during the years ended December 31, 2021, 2020 and 2019 were as follows (in thousands):
 
 For the year ended December 31,
 20212020
2019 1
Cash proceeds from options exercised$— $— $32 
Aggregate intrinsic value of options exercised$— $— $4,530 
____________________
1 During 2019, 2.1 million stock options were net exercised, wherein the option holders surrendered a portion of the underlying stock option awards to pay the exercise price and required minimum tax withholding.
Schedule of Stock Options Activity
The following table sets forth a summary of the stock option activity, weighted-average exercise prices and options outstanding as of December 31, 2021, 2020 and 2019 is as follows (in thousands, except per share amounts and years):
 For the years ended December 31,
 202120202019
 Common
Stock
Options
Weighted
Average
Exercise
Price
Common Stock OptionsWeighted Average Exercise PriceCommon
Stock
Options
Weighted
Average
Exercise
Price
Outstanding at beginning of year:$22.35 $22.35 2,105 $13.47 
Granted— $— — $— — $— 
Exercised— $— — $— (2,093)$13.45 
Expired or forfeited— $— — $— (7)$10.00 
Outstanding at end of year:$22.35 $22.35 $22.35 
Schedule of Stock Options Outstanding and Exercisable
  December 31, 2021
  Options OutstandingOptions Exercisable
Exercise Price
Total
Options
Outstanding
Weighted
Average
Remaining
Life (Years)
Weighted
Average
Exercise
Price
Number
Exercisable
Weighted
Average
Exercise
Price
22.350.2$22.35 $22.35 
Aggregate Intrinsic Value$— $—  
Schedule of Vesting Activity of Restricted Stock Units
A summary of the vesting activity of restricted stock unit awards, with the respective fair value of the awards, is as follows:
 For the year ended December 31,
 202120202019
Restricted stock awards vested317 208 172 
Fair value of awards vested$3,434 $837 $2,495 
Schedule of Fully-vested Common Stocks Issued to Non-employee Directors
A summary of the fully-vested common stock the Company issued to its six non-employee directors, in connection with its non-employee director compensation plan, is as follows:
 For the year ended December 31,
 202120202019
Awards issued51 68 30 
Grant date fair value of awards issued$525 $326 $450 
Schedule of Non-vested Restricted Share Units
A summary of the Company's outstanding, non-vested restricted share units is as follows:
For the year ended December 31,
202120202019
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
Outstanding at beginning of period:1,076 $7.41 559 $16.92 443 $20.55 
Granted528 $10.07 782 $3.79 339 $14.04 
Released(317)$10.77 (208)$18.71 (172)$20.38 
Forfeited(79)$8.82 (57)$9.62 (51)$17.71 
Outstanding at end of period:1,208 $7.96 1,076 $7.41 559 $16.92 
Schedule of Performance Shares Units Activity
A summary of the Company's PRSU activity is presented as follows:
 For the year ended December 31,
202120202019
 UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
UnitsWeighted
Average
Grant-Date
Fair Value
Outstanding at beginning of period:333 $8.84 260 $16.77 277 $17.80 
Granted189 $12.59 292 $3.68 190 $13.63 
Performance condition adjustments, net(56)$9.27 (99)$3.82 (106)$13.77 
Released(78)$8.15 (120)$17.29 (101)$17.19 
Forfeited— $— — $— — $— 
Outstanding at end of period:388 $10.07 333 $8.84 260 $16.77